Holding(s) in Company
02 April 2008 - 4:04PM
UK Regulatory
RNS Number:4391R
EiRx Therapeutics PLC
02 April 2008
Financial Services Authority
TR-1 i: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying Eirx Therapeutics Plc
issuer of existing shares to which
voting rights are attached ii:
2. Reason for notification (please tick the appropriate box or boxes)
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments which may result in the acquisition
of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the Barclays PLC
notification obligation iii:
4. Full name of shareholder(s) (if different from 3):
Barclays Stockbrokers Ltd
5. Date of transaction and date on which the threshold is 28-Mar-08
crossed or reached v:
6. Date on which issuer notified: 02-Apr-08
7. Threshold(s) that is/are crossed or reached: 11% to 9%
8. Notified details:
A: Voting rights attached to shares
Class/type Situation Resulting situation after the triggering transaction vii
of shares previous to the
Triggering
if possible transaction vi
using the ISIN
CODE
Number Number Number Number of Voting Rights % of voting rights
Of Of Of
Shares Voting Shares
Rights viii Direct x Indirect xi Direct Indirect
GB00B0XQBS97 806,354,570 806,354,570 689,459,431 0 689,459,431 0.00 9.88
B: Financial Instruments
Resulting situation after the triggering transaction xii
Type of financial Expiration Exercise/Conversion No. of voting Percentage of voting
instrument Period/Date xiv rights
date xiii rights that may be
acquired if the
instrument exercised/
converted
N/A N/A N/A N/A N/A
Total (A+B)
Number of voting rights Percentage of voting rights
689,459,431 9.88
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively
held, if applicable xv :
Barclays Stockbrokers Ltd
Proxy Voting:
10. Name of proxy holder: N/A
11. Number of voting rights proxy holder will cease N/A
to hold:
12. Date on which proxy holder will cease to hold N/A
voting rights:
13. Additional information: N/A
14. Contact name: Geoff Smith
15. Contact telephone number 020 7116 2913
Annex to Notification Of Major Interest In Shares xvi
A: Identity of the person on legal entity subject to the notification obligation
Full name (including legal form for legal entities) Barclays PLC
Contact address (registered office for legal entities) 1 Churchill Place
London E14 5HP
Phone number 020 7116 2913
Other useful information (at least legal representative for
legal persons)
B: Identity of the notifier, if applicable xvii
Full name Geoff Smith
Contact address BARCLAYS PLC
1 Churchill Place
London E14 5HP
Phone number 020 7116 2913
Other useful information (e.g. functional relationship with
the
person or legal
entity subject to the
notification
obligation)
C: Additional information
For notes on how to complete form TR-1 please see the FSA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUVORWKRSRAR
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Eirx Therap. (Londoner Börse): 0 Nachrichtenartikel
Weitere Eirx Therapeutic Plc News-Artikel